Patent: 7,576,221
✉ Email this page to a colleague
Summary for Patent: 7,576,221
Title: | Substituted imidazole derivatives |
Abstract: | The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula: ##STR00001## |
Inventor(s): | Wang; Weibo (Moraga, CA), Barsanti; Paul A. (Pleasant Hill, CA), Xia; Yia (Palo Alto, CA), Boyce; Rustum (Singapore, SG), Pecchi; Sabina (Oakland, CA), Brammeier; Nathan (Walnut Creek, CA), Phillips; Megan C. (Walnut Creek, CA), Mendenhall; Kris (Concord, CA), Wayman; Kelly (San Rafael, CA), Lagniton; Liana Marie (Berkeley, CA), Constantine; Ryan (Salt Lake City, UT), Yang; Hong (Pleasant Hill, CA), Mieuli; Elizabeth (Oakland, CA), Ramurthy; Savithri (Walnut Creek, CA), Jazan; Elisa (Richmond, CA), Sharma; Anu (El Cerrito, CA), Jain; Rama (Fremont, CA), Subramanian; Sharadha (San Ramon, CA), Renhowe; Paul A. (Danville, CA), Bair; Kenneth W. (Oakland, CA), Duhl; David (Oakland, CA), Walter; Annette (Mill Valley, CA), Abrams; Tinya (Richmond, CA), Huh; Kay (San Mateo, CA), Martin; Eric (El Cerrito, CA), Knapp; Mark (Oakland, CA), Le; Vincent P. (San Francisco, CA) |
Assignee: | Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA) |
Application Number: | 11/158,574 |
Patent Claims: | see list of patent claims |
Details for Patent 7,576,221
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2024-06-18 |
Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | 02/19/2002 | ⤷ Try a Trial | 2024-06-18 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2024-06-18 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2024-06-18 |
Genentech, Inc. | RITUXAN HYCELA | rituximab and hyaluronidase human | Injection | 761064 | 06/22/2017 | ⤷ Try a Trial | 2024-06-18 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |